Floatz logo

Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter

Fallopian Tube Undifferentiated Carcinoma

Mayo Clinicgene_therapyPhase 2Active
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
95/ 100

Competitive context

72 Active assets in the Fallopian Tube Undifferentiated Carcinoma cohort.

Asset / SponsorPhaseRating
Carboplatin
Women's Hospital School Of Medicine Zhejiang University
Phase 3BBB
CIS-DIAMMINEDICHLOROPLATINUM II
Mayo Clinic
Phase 3BB
Cyclophosphamide
Mayo Clinic
Phase 2BB
TAMOXIFEN
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Phase 3BB
Pembrolizumab
Roswell Park Cancer Institute
Phase 2BB

View all 50 →

Same molecule, other indications

Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter is also rated in:

primary peritoneal carcinomaDormant
B
Indicative ·
63 / 100
View asset →
fallopian tube serous adenocarcinomaDormant
B
Indicative ·
59 / 100
View asset →
fallopian tube mucinous adenocarcinomaDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →